Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 27, 2023
Reporting Period: Event date November 27, 2023; Transfer effective November 29, 2023.
The Company is an emerging growth company incorporated in Delaware. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "LUCD".
Key Financial Metrics
This filing is a current report regarding a listing transfer and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for these metrics.
Material Changes
- Listing Transfer: Nasdaq staff approved the transfer of the Company's common stock from the Nasdaq Global Market to the Nasdaq Capital Market.
- Effective Date: The transfer occurred at the open of business on November 29, 2023.
- Trading Status: Trading continues under the symbol "LUCD" and is unaffected by the transfer.
- Reason for Transfer: The Company previously received notice on November 21, 2023, of non-compliance with the Equity standard for the Nasdaq Global Market. The Company also did not meet alternative standards for Market Value or Total Assets/Total Revenue. The transfer resolves this deficiency as the Company meets the continued listing standards for the Nasdaq Capital Market.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary risk addressed is the prior failure to satisfy the Equity standard for the Nasdaq Global Market, which has been resolved by the transfer to the Nasdaq Capital Market. The filing notes that the Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market.
Investor Verification Checklist
- Verify the current trading status and symbol ("LUCD") on the Nasdaq Capital Market.
- Review the Company's most recent 10-K or 10-Q filings to assess the specific financial metrics (Equity, Market Value, Total Assets/Revenue) that led to the delisting from the Global Market.
- Confirm that the transfer to the Nasdaq Capital Market does not impact the Company's ability to raise capital or maintain investor confidence.